Literature DB >> 21833527

Evaluation of the T helper 17 axis in ankylosing spondylitis.

Ali Taylan1, Ismail Sari, Didem L Kozaci, Arif Yuksel, Safak Bilge, Yasar Yildiz, Gulten Sop, Isil Coker, Necati Gunay, Nurullah Akkoc.   

Abstract

To evaluate the T helper 17 (Th17) axis and its relation to tumor necrosis factor (TNF) alpha blockage and disease activity in ankylosing spondylitis (AS). The study included 127 AS patients (100M/27F) and 38 (27M/11F) controls. Spinal mobility was assessed by the bath ankylosing spondylitis metrology index (BASMI). Patients were also evaluated with the bath ankylosing spondylitis functional (BASFI) and bath ankylosing spondylitis disease activity index. Cytokines including IL-6, IL-12, TGF-β, IL-17A, and IL-23 were measured in serum sample using commercially available ELISA kits. Cytokines including IL-6, IL-12, TGF-β, IL-17, and IL-23 were significantly higher in the AS patients than the controls (P < 0.05). The Th-17-related cytokines were not different between patients treated with anti-TNF and conventional therapies (P > 0.05). Cytokines were also similar between patients with active and inactive disease (P > 0.05). On correlation analysis, IL-17 was correlated with IL-23 and IL-12 (P < 0.05) and IL-23 showed correlations with IL-12 and BASMI (P < 0.05). We found serum levels of Th-17-related cytokines to be significantly increased in the sera of AS patients. Disease activity and treatment type did not affect the level of these cytokines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833527     DOI: 10.1007/s00296-011-1995-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

Review 1.  The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.

Authors:  Kristine Kikly; Ling Liu; Songqing Na; Jonathon D Sedgwick
Journal:  Curr Opin Immunol       Date:  2006-09-28       Impact factor: 7.486

2.  Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis.

Authors:  Daniel Wendling; Jean-Pierre Cedoz; Evelyne Racadot; Gilles Dumoulin
Journal:  Joint Bone Spine       Date:  2007-02-20       Impact factor: 4.929

3.  Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides.

Authors:  Camilla Jandus; Gilles Bioley; Jean-Paul Rivals; Jean Dudler; Daniel Speiser; Pedro Romero
Journal:  Arthritis Rheum       Date:  2008-08

4.  Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series.

Authors:  Tugce Karaderi; David Harvey; Claire Farrar; Louise H Appleton; Millicent A Stone; Roger D Sturrock; Matthew A Brown; Paul Wordsworth; Jennifer J Pointon
Journal:  Rheumatology (Oxford)       Date:  2009-02-02       Impact factor: 7.580

5.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

Review 6.  The Interleukin-23 / Interleukin-17 axis in intestinal inflammation.

Authors:  Kevin J Maloy
Journal:  J Intern Med       Date:  2008-06       Impact factor: 8.989

7.  Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.

Authors:  Hui Shen; Jane C Goodall; J S Hill Gaston
Journal:  Arthritis Rheum       Date:  2009-06

8.  The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis.

Authors:  B Rueda; G Orozco; E Raya; J L Fernandez-Sueiro; J Mulero; F J Blanco; C Vilches; M A González-Gay; J Martin
Journal:  Ann Rheum Dis       Date:  2008-01-16       Impact factor: 19.103

9.  Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis.

Authors:  Xinwei Wang; Zhiming Lin; Qiujing Wei; Yingjuan Jiang; Jieruo Gu
Journal:  Rheumatol Int       Date:  2009-02-27       Impact factor: 2.631

10.  Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy.

Authors:  Rajeev Singh; Amita Aggarwal; Ramnath Misra
Journal:  J Rheumatol       Date:  2007-10-15       Impact factor: 4.666

View more
  12 in total

1.  Erythema elevatum diutinum coexisting with ankylosing spondylitis.

Authors:  Fatih Yıldız; Tuğba Karakaş; Arbil Açıkalın; Didem Arslan Taş; Eren Erken
Journal:  Eur J Rheumatol       Date:  2015-03-31

2.  Is RUNX3 a new player in the pathogenesis of ankylosing spondylitis?

Authors:  Zhen Zeng; Zhenhua Duan; Shengqian Xu; Faming Pan
Journal:  Rheumatol Int       Date:  2012-07-20       Impact factor: 2.631

Review 3.  Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis.

Authors:  Akihiro Nakamura; Nigil Haroon
Journal:  Curr Rheumatol Rep       Date:  2021-04-24       Impact factor: 4.592

4.  The synergistic role of TNFA - 308G/A and IL10 - 1082A/G polymorphisms in ankylosing spondylitis.

Authors:  Mariana Ivanova; Irena Manolova; Rumen Stoilov; Spaska Stanilova
Journal:  Rheumatol Int       Date:  2021-09-04       Impact factor: 2.631

5.  Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.

Authors:  Li Xueyi; Chen Lina; Wu Zhenbiao; Han Qing; Li Qiang; Ping Zhu
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

6.  Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity.

Authors:  Bingni Chen; Kunzhao Huang; Liang Ye; Yanqun Li; Jiawei Zhang; Jinshun Zhang; Xinmin Fan; Xiaokai Liu; Li Li; Jinxia Sun; Jing Du; Zhong Huang
Journal:  J Transl Med       Date:  2015-01-28       Impact factor: 5.531

7.  All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study.

Authors:  Deng Li; Peng Wang; Yuxi Li; Zhongyu Xie; Le Wang; Hongjun Su; Wen Deng; Yanfeng Wu; Huiyong Shen
Journal:  Stem Cells Int       Date:  2015-06-01       Impact factor: 5.443

8.  Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors.

Authors:  Inês P Perpétuo; Joana Caetano-Lopes; Elsa Vieira-Sousa; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca
Journal:  Front Med (Lausanne)       Date:  2017-01-27

9.  Ankylosing spondylitis: from cells to genes.

Authors:  José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2013-07-21

10.  Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis.

Authors:  Cristina F Rabelo; Talita Siara Almeida Baptista; Laura Esteves Petersen; Moisés Evandro Bauer; Mauro Waldemar Keiserman; Henrique Luiz Staub
Journal:  Open Access Rheumatol       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.